Ballentine Partners, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024
SELL
$1.26 - $1.79 $2,537 - $3,605
-2,014 Reduced 16.66%
10,074 $17,000
Q3 2023

Oct 19, 2023
BUY
$1.61 - $2.54 $19,461 - $30,703
12,088 New
12,088 $21,000
Q1 2023

Apr 27, 2023
SELL
$1.2 - $2.19 $14,488 - $26,442
-12,074 Reduced 53.43%
10,522 $13,000
Q4 2022

Jan 27, 2023
BUY
$1.63 - $3.52 $36,831 - $79,537
22,596 New
22,596 $0

Others Institutions Holding DNA

# of Institutions
41
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $11.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email